The single use bioreactors market is anticipated to witness substantial growth, projected to reach USD 10.0 billion by 2028, with a CAGR of 19.0% during the forecast period from 2023 to 2028. Several factors are driving this growth, including the increasing adoption of single-use bioreactors among startups and small to medium-sized enterprises (SMEs). These bioreactors offer advantages such as lower operational complexity compared to conventional stainless-steel bioreactors, reduced energy and water consumption, and technological advancements.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=44374840

One of the key factors contributing to market growth is the expanding size of the biologics and biosimilars market. As the demand for these products increases, the need for efficient and cost-effective manufacturing processes also rises, leading to a greater adoption of single-use bioreactors.

The research report highlights that the monoclonal antibodies (mAbs) segment holds the largest share of the molecule type segment in the single-use bioreactors market in 2022. This can be attributed to the growing demand for mAbs in various therapeutic applications and the benefits offered by single-use bioreactors, such as reduced investment costs and time-intensive changeover procedures.

In terms of cell type, the mammalian cells segment is projected to experience the fastest growth in the single-use bioreactors market. The adoption of mammalian cells is increasing due to their capacity for post-translational modifications and the assembly of human protein-like molecular structures, which are essential in biopharmaceutical production.

The Asia Pacific region is identified as the fastest-growing region in the single-use bioreactors market in 2022. Factors such as the growing biopharmaceutical industry, increased investments by pharmaceutical and biotechnology companies, and the presence of contract research organizations (CROs) and contract manufacturing organizations (CMOs) contribute to the market's growth in this region.

Key players in the single-use bioreactors market include Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, and Merck Millipore. These companies are at the forefront of driving innovation and providing advanced solutions in the field of single-use bioreactors.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=44374840

Overall, the single-use bioreactors market is poised for significant growth, driven by factors such as the adoption of these bioreactors by startups and SMEs, advantages over traditional bioreactors, the expanding biologics and biosimilars market, and technological advancements. The dominance of the monoclonal antibodies segment, the rapid growth of mammalian cells, and the promising prospects in the Asia Pacific region further contribute to the market's positive outlook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]